Nifty
Sensex
:
:
25149.85
82500.47
-205.40 (-0.81%)
-689.81 (-0.83%)

Medical Equipment/Supplies/Accessories

Rating :
N/A

BSE: 531768 | NSE: POLYMED

2219.00
11-Jul-2025
  • Open
  • High
  • Low
  • Previous Close
  •  2229.9
  •  2231.5
  •  2201.3
  •  2219.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  40586
  •  89994321.8
  •  3357.8
  •  1810.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 22,466.44
  • 66.36
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 22,493.11
  • 0.16%
  • 8.12

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.44%
  • 2.24%
  • 11.07%
  • FII
  • DII
  • Others
  • 11.44%
  • 9.95%
  • 2.86%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.43
  • 14.89
  • 14.23

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.40
  • 16.76
  • 10.89

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.40
  • 22.47
  • 20.80

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 52.21
  • 61.40
  • 63.57

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.18
  • 9.21
  • 9.41

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 29.59
  • 37.28
  • 41.07

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
26.92
33.41
39.67
49.5
P/E Ratio
8.39
6.76
5.69
4.56
Revenue
1366
1670
2028
2454
EBITDA
358
453
562
697
Net Income
258
339
407
507
ROA
15
13.4
12.2
13.1
P/B Ratio
1.49
0.83
0.73
0.64
ROE
19.05
15.99
13.4
14.72
FCFF
-8
-87
170
248
FCFF Yield
-0.04
-0.38
0.75
1.09
Net Debt
-112
-1028
-1213
-1420
BVPS
151.95
272.95
308.75
352.83

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
440.83
378.07
16.60%
424.21
339.60
24.91%
420.01
337.29
24.52%
384.78
320.83
19.93%
Expenses
321.37
281.50
14.16%
309.67
249.38
24.18%
304.69
253.06
20.40%
280.86
233.64
20.21%
EBITDA
119.46
96.58
23.69%
114.54
90.22
26.96%
115.33
84.23
36.92%
103.92
87.19
19.19%
EBIDTM
27.10%
25.55%
27.00%
26.57%
27.46%
24.97%
27.01%
27.18%
Other Income
24.31
14.97
62.39%
21.80
16.57
31.56%
26.10
14.09
85.24%
16.92
13.12
28.96%
Interest
2.17
3.13
-30.67%
3.33
3.47
-4.03%
3.34
2.22
50.45%
3.16
2.49
26.91%
Depreciation
21.03
16.20
29.81%
21.51
16.21
32.70%
20.85
15.99
30.39%
19.65
15.53
26.53%
PBT
120.58
92.23
30.74%
111.51
87.11
28.01%
117.23
80.11
46.34%
98.02
82.29
19.12%
Tax
31.01
24.10
28.67%
28.00
22.81
22.75%
30.53
18.76
62.74%
24.42
20.34
20.06%
PAT
89.56
68.13
31.45%
83.51
64.30
29.88%
86.70
61.35
41.32%
73.60
61.95
18.81%
PATM
20.32%
18.02%
19.69%
18.93%
20.64%
18.19%
19.13%
19.31%
EPS
9.06
7.12
27.25%
8.41
6.78
24.04%
8.63
6.48
33.18%
7.71
6.53
18.07%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,669.83
1,375.80
1,115.23
923.06
786.47
687.24
610.83
520.42
455.01
412.26
390.35
Net Sales Growth
21.37%
23.36%
20.82%
17.37%
14.44%
12.51%
17.37%
14.38%
10.37%
5.61%
 
Cost Of Goods Sold
554.69
393.31
321.72
281.60
212.45
170.01
164.86
124.64
116.82
114.12
110.64
Gross Profit
1,115.14
982.49
793.51
641.47
574.02
517.23
445.97
395.78
338.19
298.14
279.70
GP Margin
66.78%
71.41%
71.15%
69.49%
72.99%
75.26%
73.01%
76.05%
74.33%
72.32%
71.65%
Total Expenditure
1,216.59
1,015.31
847.83
708.05
569.98
521.11
479.59
398.46
361.54
324.50
304.27
Power & Fuel Cost
-
44.29
38.59
29.84
25.27
25.62
24.74
19.04
16.78
15.22
13.16
% Of Sales
-
3.22%
3.46%
3.23%
3.21%
3.73%
4.05%
3.66%
3.69%
3.69%
3.37%
Employee Cost
-
245.91
202.75
163.62
141.76
138.76
116.61
99.13
87.26
74.77
64.99
% Of Sales
-
17.87%
18.18%
17.73%
18.02%
20.19%
19.09%
19.05%
19.18%
18.14%
16.65%
Manufacturing Exp.
-
234.05
208.57
172.94
138.87
129.76
121.66
112.98
96.95
85.38
83.50
% Of Sales
-
17.01%
18.70%
18.74%
17.66%
18.88%
19.92%
21.71%
21.31%
20.71%
21.39%
General & Admin Exp.
-
49.42
38.99
32.52
29.26
33.72
29.74
21.22
21.02
16.70
13.97
% Of Sales
-
3.59%
3.50%
3.52%
3.72%
4.91%
4.87%
4.08%
4.62%
4.05%
3.58%
Selling & Distn. Exp.
-
27.25
20.99
15.68
13.80
15.37
15.89
13.98
17.02
12.88
14.28
% Of Sales
-
1.98%
1.88%
1.70%
1.75%
2.24%
2.60%
2.69%
3.74%
3.12%
3.66%
Miscellaneous Exp.
-
21.08
16.23
11.86
8.57
7.87
6.10
7.48
5.70
5.42
14.28
% Of Sales
-
1.53%
1.46%
1.28%
1.09%
1.15%
1.00%
1.44%
1.25%
1.31%
0.95%
EBITDA
453.25
360.49
267.40
215.01
216.49
166.13
131.24
121.96
93.47
87.76
86.08
EBITDA Margin
27.14%
26.20%
23.98%
23.29%
27.53%
24.17%
21.49%
23.43%
20.54%
21.29%
22.05%
Other Income
89.13
58.75
36.19
37.90
18.41
18.46
18.48
14.38
13.53
8.27
8.12
Interest
12.00
13.56
10.86
6.16
10.64
20.48
13.75
11.58
8.67
9.95
10.25
Depreciation
83.04
63.93
57.17
53.95
47.52
40.53
37.29
29.24
23.73
21.03
18.77
PBT
447.34
341.74
235.56
192.80
176.74
123.58
98.68
95.51
74.60
65.04
65.17
Tax
113.96
86.01
58.21
48.74
44.18
29.85
34.68
26.16
20.06
17.57
23.10
Tax Rate
25.48%
25.17%
24.71%
25.28%
25.00%
24.15%
35.14%
27.39%
26.89%
27.01%
27.26%
PAT
333.37
258.26
179.28
146.51
135.87
93.74
64.00
69.35
54.54
47.47
61.65
PAT before Minority Interest
333.37
258.26
179.28
146.51
135.87
93.74
64.00
69.35
54.54
47.47
61.65
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
19.96%
18.77%
16.08%
15.87%
17.28%
13.64%
10.48%
13.33%
11.99%
11.51%
15.79%
PAT Growth
30.36%
44.05%
22.37%
7.83%
44.94%
46.47%
-7.71%
27.15%
14.89%
-23.00%
 
EPS
32.91
25.49
17.70
14.46
13.41
9.25
6.32
6.85
5.38
4.69
6.09

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
1,470.05
1,241.63
1,087.48
965.57
434.82
381.37
338.30
271.54
228.63
196.18
Share Capital
47.99
47.97
47.95
47.94
44.12
44.12
44.11
44.11
22.06
22.06
Total Reserves
1,418.67
1,191.35
1,038.01
916.84
390.56
336.95
293.77
227.43
206.57
174.12
Non-Current Liabilities
37.38
42.28
62.68
86.76
139.23
118.99
103.95
71.56
49.48
55.22
Secured Loans
1.09
11.56
30.56
59.74
114.41
91.38
79.12
47.62
31.06
40.25
Unsecured Loans
0.00
5.94
7.56
3.54
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
5.99
4.60
3.98
3.27
3.80
3.13
2.10
3.33
2.57
2.04
Current Liabilities
424.61
351.17
226.68
215.10
225.49
181.24
122.58
113.85
109.25
112.62
Trade Payables
95.60
92.31
89.04
64.52
66.36
55.54
43.62
41.86
30.87
39.33
Other Current Liabilities
100.60
92.72
78.57
66.90
72.25
48.99
46.39
39.32
39.89
38.66
Short Term Borrowings
150.91
106.88
58.72
38.82
53.18
45.47
32.24
32.30
33.46
21.05
Short Term Provisions
77.50
59.25
0.35
44.86
33.71
31.24
0.33
0.38
5.03
13.58
Total Liabilities
1,932.04
1,635.08
1,376.84
1,267.43
799.54
681.60
564.83
456.95
387.36
364.02
Net Block
866.81
634.35
484.23
421.22
359.49
302.74
261.79
206.07
182.35
165.47
Gross Block
1,311.18
1,018.82
818.46
706.56
599.92
507.83
430.48
344.86
298.59
261.15
Accumulated Depreciation
444.38
384.47
334.23
285.34
240.42
205.09
168.69
138.79
116.24
95.68
Non Current Assets
1,017.05
770.52
593.40
519.62
449.54
352.28
309.62
252.03
216.76
204.51
Capital Work in Progress
75.71
78.16
43.40
21.21
24.71
19.42
18.25
20.00
13.72
9.80
Non Current Investment
27.57
7.64
9.77
9.40
12.92
10.79
10.28
3.92
4.42
3.95
Long Term Loans & Adv.
38.63
41.89
32.25
12.73
19.54
8.82
13.70
17.45
12.89
22.04
Other Non Current Assets
7.75
7.58
19.88
50.54
32.88
10.51
5.60
4.59
3.38
3.25
Current Assets
915.00
864.55
783.44
747.81
350.00
329.32
255.20
204.92
170.60
159.50
Current Investments
139.54
124.02
336.60
345.01
15.92
0.27
10.62
0.00
0.00
0.00
Inventories
221.03
208.65
168.36
126.48
112.09
83.79
72.99
61.95
46.00
57.62
Sundry Debtors
269.94
235.43
206.63
155.86
127.12
128.38
112.54
95.53
82.98
62.81
Cash & Bank
146.86
177.63
15.44
29.56
25.36
54.59
20.39
22.68
21.73
19.98
Other Current Assets
137.63
15.75
12.44
22.01
69.51
62.29
38.66
24.77
19.89
19.09
Short Term Loans & Adv.
120.73
103.06
43.98
68.88
56.20
40.83
16.65
10.29
10.97
9.73
Net Current Assets
490.39
513.38
556.76
532.71
124.51
148.08
132.63
91.07
61.35
46.88
Total Assets
1,932.05
1,635.07
1,376.84
1,267.43
799.54
681.60
564.82
456.95
387.36
364.01

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
266.08
191.05
123.47
118.73
128.30
106.48
74.96
56.07
63.20
63.30
PBT
344.27
237.49
195.24
180.05
125.72
98.68
95.51
74.60
65.04
65.17
Adjustment
36.77
60.89
39.08
44.48
50.59
44.23
39.93
23.28
26.00
42.95
Changes in Working Capital
-40.66
-49.46
-63.39
-61.19
-12.07
-8.69
-37.35
-23.60
-13.95
-20.96
Cash after chg. in Working capital
340.38
248.92
170.93
163.35
164.24
134.21
98.09
74.28
77.09
87.17
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-74.30
-57.87
-47.46
-44.62
-35.93
-27.72
-23.14
-18.21
-13.89
-23.30
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-240.94
-179.24
-85.33
-435.58
-107.26
-100.74
-88.03
-55.67
-31.38
-59.33
Net Fixed Assets
-284.72
-233.08
-131.91
-100.55
-95.55
-43.89
-82.07
-51.29
-40.24
-48.59
Net Investments
-39.63
202.56
1.27
-323.40
-15.59
-24.01
-15.56
-0.64
0.00
0.00
Others
83.41
-148.72
45.31
-11.63
3.88
-32.84
9.60
-3.74
8.86
-10.74
Cash from Financing Activity
-20.15
-12.51
-35.34
316.95
-20.51
-5.13
15.71
-0.28
-30.77
-5.89
Net Cash Inflow / Outflow
4.99
-0.70
2.80
0.10
0.54
0.62
2.64
0.11
1.06
-1.91
Opening Cash & Equivalents
7.06
7.76
4.95
4.86
4.32
3.70
1.06
0.95
11.86
13.77
Closing Cash & Equivalent
12.05
7.06
7.76
4.95
4.86
4.32
3.70
1.06
12.91
11.86

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
152.82
129.17
113.24
100.62
49.26
43.19
38.30
30.78
25.91
22.24
ROA
14.48%
11.90%
11.08%
13.15%
12.66%
10.27%
13.58%
12.92%
12.64%
18.97%
ROE
19.09%
15.42%
14.29%
19.42%
22.98%
17.80%
22.76%
21.81%
22.35%
36.03%
ROCE
23.63%
19.10%
17.42%
21.96%
24.43%
22.19%
25.39%
24.37%
25.59%
38.90%
Fixed Asset Turnover
1.19
1.22
1.22
1.21
1.24
1.30
1.35
1.44
1.49
1.71
Receivable days
66.78
72.05
71.34
65.34
67.85
71.98
72.79
70.54
63.66
50.14
Inventory Days
56.78
61.45
58.03
55.09
52.02
46.84
47.20
42.65
45.25
46.02
Payable days
87.19
102.88
99.52
112.43
41.75
38.03
38.55
36.95
39.11
41.04
Cash Conversion Cycle
36.37
30.62
29.84
8.01
78.12
80.80
81.45
76.24
69.80
55.12
Total Debt/Equity
0.12
0.12
0.12
0.14
0.47
0.42
0.39
0.37
0.36
0.40
Interest Cover
26.38
22.87
32.68
17.92
7.04
8.18
9.25
9.61
7.54
9.27

News Update:


  • Poly Medicure reports 34% jump in Q4 consolidated net profit
    7th May 2025, 15:22 PM

    The total consolidated income of the company increased by 18.34% at Rs 465.14 crore for Q4FY25

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.